Division of General Internal Medicine and Public Health Archive — Page 5 of 7

April 2, 2020

Study aims to shield health workers from COVID-19 infection

VUMC is playing a key role in a national effort to establish a registry of U.S. health care workers and test whether the anti-malarial drug hydroxychloroquine (HCQ) will protect them, their patients and their families from COVID-19.

October 3, 2019

Diabetes drug study explores cardiovascular risks for patients with kidney disease

An observational study using medical record information from nearly 50,000 U.S. military veterans sheds new light on which drugs are best for patients with Type 2 diabetes and one of its common complications, kidney disease.

September 12, 2019

Study shows benefit of palliative care for liver disease patients

A Vanderbilt study sheds new light on the impact of palliative care.

August 20, 2019

Quitting smoking associated with lower risk of cardiovascular disease

A new Vanderbilt study documents the great incentive for current smokers to quit.

Russell Rothman, MD, MPP, speaks at last week’s MidSouth Practice Transformation Network (PTN): Vanderbilt Health Affiliated Network Summer Summit.
July 25, 2019

Summit highlights clinical improvement successes

A summit at Vanderbilt reviewed achievements of an ongoing regional effort to transform clinical practices in ways that would improve the quality of patient care, reduce costs and improve health outcomes

January 10, 2019

Clinical Data Research Network primed for growth

The Mid-South Clinical Data Research Network, led by Vanderbilt University Medical Center’s Russell Rothman, MD, MPP, is a collaborative effort among a group of large health care systems to support and conduct innovative comparative effectiveness research and clinical trials.